Valneva SE (VALN)
NASDAQ: VALN · Real-Time Price · USD
9.54
+0.80 (9.15%)
At close: Nov 26, 2025, 4:00 PM EST
9.55
+0.01 (0.10%)
After-hours: Nov 26, 2025, 7:49 PM EST
Valneva SE Market Cap
Valneva SE has a market cap or net worth of $856.46 million as of November 26, 2025. Its market cap has increased by 133.43% in one year.
Market Cap
856.46M
Enterprise Value
917.21M
1-Year Change
133.43%
Ranking
Category
Stock Price
$9.54
Market Cap Chart
Since the IPO on June 3, 2014, Valneva SE's market cap has increased from $450.94M to $856.46M, an increase of 89.93%. That is a compound annual growth rate of 5.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 27, 2025 | 856.46M | 135.62% |
| Dec 31, 2024 | 363.50M | -49.80% |
| Dec 29, 2023 | 724.08M | -21.32% |
| Dec 30, 2022 | 920.30M | -68.57% |
| Dec 31, 2021 | 2.93B | 239.54% |
| Dec 31, 2020 | 862.29M | 228.84% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 988.81B |
| Johnson & Johnson | 500.07B |
| AbbVie | 402.36B |
| UnitedHealth Group | 298.66B |
| AstraZeneca | 290.32B |
| Merck & Co. | 259.69B |
| Novartis AG | 251.09B |
| Abbott Laboratories | 223.51B |